Abstract
In the present study, we investigated the mechanism of phenylephrine (alpha-1-adrenergic receptor agonist)-induced arachidonic acid release in Japanese white rabbit aortic smooth muscle cells (SMC). When introduced into permeabilized smooth muscle cells, guanosine S-[gamma-thio] triphosphate (GTPgamma S), which activates GTP-binding proteins (G proteins), stimulated arachidonic acid (AA) release. Neomycin, an inhibitor of phosphoinositide (PI) turnover, was almost without effect on GTP[gamma S] stimulated AA release. In addition, pertussis toxin (PT) partially inhibited phenylephrine-stimulated AA release, suggesting that IAP (Islet activating protein)-sensitive G proteins mediate this process. Phenylephrine-stimulated AA release was also inhibited by decreased extracellular calcium and aristolochic acid, suggesting a role for a phospholipase A2 (PLA2). Next PLA2 is reported to be a substrate for mitogen-activated protein (MAP) kinase. We examined the effect of phenylephrine on MAP kinase and c-jun N-terminal kinase (JNK) phosphorylation. Phenylephrine didn't induce phosphorylation of MAP kinase, but did induce phosphorylation of JNK. In addition, cells which were pretreated with PT inhibited the phosphorylation of JNK. These r...Continue Reading
Citations
May 9, 2002·Biological & Pharmaceutical Bulletin·Taka-aki KoshimizuGozoh Tsujimoto
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·X L Cui, J G Douglas
Jan 8, 1998·British Journal of Pharmacology·E Nishio, Y Watanabe
Jun 1, 1997·British Journal of Pharmacology·E Nishio, Y Watanabe
Oct 7, 2000·Neuropeptides·J DisaN Aiyar
May 9, 2012·Regulatory Peptides·Hong XueLimin Lu
Jan 24, 1998·European Journal of Pharmacology·E Nishio, Y Watanabe
Apr 27, 2007·Journal of Hepatology·Jorge Gracia-SanchoJoan Carles García-Pagán
Mar 1, 2014·Inflammation·Meihua JinDexin Kong
Sep 21, 2000·Journal of Cellular Biochemistry·H C Wen, W W Lin
Jul 17, 1998·Circulation·C P TiefenbacherW M Chilian
Jan 6, 2006·The Journal of Pharmacology and Experimental Therapeutics·Rui ZhangKathleen M MacLeod
Oct 18, 2000·The Journal of Biological Chemistry·T PomorskiM Naumann
Feb 12, 1998·The American Journal of Physiology·E J FreemanR V Dorman
Jun 1, 1999·Journal of Neurochemistry·H Zhong, K P Minneman
Nov 6, 1998·Molecular Pharmacology·A AlexandrovM C Michel
Mar 22, 2001·Molecular Pharmacology·H Q WangR C Smart
Sep 28, 2001·Biochemical and Biophysical Research Communications·R A Houliston, C P Wheeler-Jones
Jul 30, 1999·Biochemical and Biophysical Research Communications·A AlexandrovM C Michel
Feb 24, 1998·European Journal of Pharmacology·E Nishio, Y Watanabe
May 7, 1998·European Journal of Pharmacology·A HuwilerJ Pfeilschifter
Jun 6, 2000·Trends in Neurosciences·M HernándezM Sánchez Crespo
Jul 28, 1999·European Journal of Pharmacology·E Nishio, Y Watanabe
Aug 12, 1999·European Journal of Pharmacology·H Zhong, K P Minneman
Aug 26, 1998·Life Sciences·E Nishio, Y Watanabe
Feb 20, 2003·European Journal of Pharmacology·Andre S PupoKenneth P Minneman
May 12, 2004·Atherosclerosis·José Martínez-GonzálezLina Badimon